ACTRN12620000478910尚未招募未知
Cord Blood Therapy to prevent progression of COVID-19 related pneumonia
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Hospitalised patients with confirmed SARS-CoV2 infection (based on appropriate nucleic acid or other testing), and
- •1)Expected to remain an in-patient for at least 48 hours with
- •2)Features consistent with viral pneumonia on Chest CT or X-Ray (in the opinion of the investigator) and
- •3)Are unable to maintain a peripheral oxygen saturation of 95% or greater in room air
排除标准
- •1)Patients with known allergies to stem cell preparations
- •2)Patients with known significant lung disease before COVID-19 presentation
- •3)Receiving invasive/ mechanical ventilatory support
- •4)Patients with underlying disease, comorbidities or clinical status that in the opinion of the investigator suggests death is imminent and/or likely to occur the next 48 hours
- •5)Currently on other investigational stem cell therapies
- •6)Known pregnancy
- •7)Patient unable to provide consent
- •8)The treating team deems that enrolment in the study is not in the best interests of the patient.
研究者
相似试验
已完成
不适用
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trialCOVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000557932AProf Dr Karin Ried446
招募中
1 期
Therapies to prevent progression of COVID-19 in outpatients: The 'Primary Care Australian COVID-19 Therapeutics' (PACT) TrialACTRN12622000386730AProf Dr Karin Ried300
撤回
不适用
International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial - Stage 2COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12622000309785AProf Dr Karin Ried200
暂停
2 期
Convalescent Antibody-Mediated Treatment of COVID-19 Infections in Patients with B-cell dysfunction, a Randomized Trial (COVID-Compromise Study).NL-OMON51203Academisch Medisch Centrum86
招募中
不适用
COVID-CompromiseNL-OMON25136AmsterdamUMC86